Overview

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Status:
Completed
Trial end date:
2019-04-12
Target enrollment:
Participant gender:
Summary
In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Dulaglutide
Immunoglobulin Fc Fragments